Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging condition, and biologic therapies are transforming patient outcomes. This masterclass will provide an up-to-date overview of the latest real-world evidence (RWE) data on three key biologics in CRSwNP as of 2025.
Click here to access the programme of this masterclass.
Participants will:
Designed for ENT specialists, allergists, pulmonologists, and all clinicians managing CRSwNP, this session will combine evidence-based updates with expert perspectives to support confident, individualised treatment decisions.
👉 This masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with 1.0 European CME credits (ECMEC) and is valid for 6 months from the event date.
The Real-World Effectiveness in Biologics for CRSwNP, Virtual, Belgium 20/11/2025 - 20/11/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
